UBS AM
XYL icon

UBS AM’s Xylem XYL Stock Holding History

UBS AM’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505M Buy
4,274,761
+440,210
+11% +$50.8M 0.09% 179
2026
Q1 		$458M Buy
3,834,551
+270,725
+8% +$35.5M 0.1% 189
2025
Q4 		$485M Sell
3,563,826
-94,084
-3% -$13.5M 0.1% 161
2025
Q3 		$540M Sell
3,657,910
-968,940
-21% -$134M 0.12% 149
2025
Q2 		$599M Buy
4,626,850
+602,350
+15% +$72.9M 0.12% 159
2025
Q1 		$481M Buy
4,024,500
+274,123
+7% +$34M 0.12% 170
2024
Q4 		$435M Buy
3,750,377
+301,070
+9% +$38.1M 0.1% 175
2024
Q3 		$466M Buy
3,449,307
+32,645
+1% +$4.37M 0.12% 158
2024
Q2 		$463M Buy
3,416,662
+770,782
+29% +$105M 0.13% 132
2024
Q1 		$342M Buy
2,645,880
+4,185
+0.2% +$506K 0.12% 163
2023
Q4 		$302M Buy
2,641,695
+54,354
+2% +$5.42M 0.12% 175
2023
Q3 		$236M Buy
2,587,341
+1,214,065
+88% +$125M 0.11% 199
2023
Q2 		$144M Hold
1,373,276
– – 0.07% 307
2023
Q1 		$144M Sell
1,373,276
-12,870
-0.9% -$1.34M 0.07% 307
2022
Q4 		$153M Buy
1,386,146
+98,666
+8% +$10.3M 0.08% 277
2022
Q3 		$112M Buy
1,287,480
+79,715
+7% +$7.25M 0.06% 338
2022
Q2 		$94.4M Sell
1,207,765
-78,961
-6% -$6.52M 0.05% 389
2022
Q1 		$110M Buy
1,286,726
+100,759
+8% +$9.65M 0.05% 409
2021
Q4 		$142M Sell
1,185,967
-6,011
-0.5% -$746K 0.05% 358
2021
Q3 		$147M Buy
1,191,978
+8,014
+0.7% +$1.03M 0.06% 322
2021
Q2 		$142M Sell
1,183,964
-17,686
-1% -$2.02M 0.06% 336
2021
Q1 		$126M Buy
1,201,650
+51,254
+4% +$5.2M 0.06% 361
2020
Q4 		$117M Buy
1,150,396
+105,452
+10% +$9.91M 0.05% 356
2020
Q3 		$87.9M Buy
1,044,944
+81,068
+8% +$6.31M 0.05% 369
2020
Q2 		$62.6M Sell
963,876
-59,243
-6% -$3.91M 0.04% 434
2020
Q1 		$66.6M Buy
1,023,119
+87,583
+9% +$6.9M 0.05% 379
2019
Q4 		$73.7M Buy
935,536
+2,890
+0.3% +$225K 0.05% 425
2019
Q3 		$74.3M Buy
932,646
+113,917
+14% +$8.95M 0.05% 392
2019
Q2 		$68.5M Sell
818,729
-1,251
-0.2% -$99.7K 0.05% 413
2019
Q1 		$64.8M Buy
819,980
+20,497
+3% +$1.5M 0.05% 407
2018
Q4 		$53.3M Buy
799,483
+41,367
+5% +$2.86M 0.05% 434
2018
Q3 		$60.6M Buy
758,116
+12,995
+2% +$970K 0.05% 430
2018
Q2 		$50.2M Buy
745,121
+99,090
+15% +$7.19M 0.04% 493
2018
Q1 		$49.7M Buy
646,031
+102,702
+19% +$7.59M 0.04% 497
2017
Q4 		$37.1M Buy
543,329
+1,945
+0.4% +$129K 0.03% 551
2017
Q3 		$33.9M Buy
541,384
+19,220
+4% +$1.15M 0.03% 560
2017
Q2 		$28.9M Buy
522,164
+47,623
+10% +$2.48M 0.03% 600
2017
Q1 		$23.8M Buy
474,541
+40,904
+9% +$1.99M 0.02% 656
2016
Q4 		$21.5M Sell
433,637
-5,134
-1% -$260K 0.02% 654
2016
Q3 		$23M Buy
438,771
+9,244
+2% +$453K 0.02% 629
2016
Q2 		$19.2M Sell
429,527
-177
-0% -$7.69K 0.02% 691
2016
Q1 		$17.6M Sell
429,704
-12,004
-3% -$442K 0.02% 701
2015
Q4 		$16.1M Sell
441,708
-71,530
-14% -$2.59M 0.02% 739
2015
Q3 		$16.9M Sell
513,238
-79,744
-13% -$2.68M 0.02% 732
2015
Q2 		$22M Buy
592,982
+34,511
+6% +$1.26M 0.02% 689
2015
Q1 		$19.6M Sell
558,471
-52,004
-9% -$1.83M 0.02% 711
2014
Q4 		$23.2M Buy
610,475
+3,062
+0.5% +$112K 0.02% 661
2014
Q3 		$21.6M Buy
607,413
+11,238
+2% +$418K 0.02% 662
2014
Q2 		$23.3M Buy
596,175
+3,486
+0.6% +$130K 0.02% 637
2014
Q1 		$21.6M Buy
592,689
+34,011
+6% +$1.24M 0.02% 648
2013
Q4 		$19.3M Buy
558,678
+8,232
+1% +$265K 0.02% 651
2013
Q3 		$15.4M Buy
550,446
+16,040
+3% +$428K 0.02% 681
2013
Q2 		$14.4M Buy
+534,406
New +$14.8M 0.02% 672

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

UBS AM's XYL Position: Q2 2026 in Review

UBS AM increased its Xylem (XYL) stake by 11% in Q2 2026, buying an estimated $50.8M and bringing the position to 4,274,761 shares worth $505M. The position accounts for 0.09% of the portfolio, ranked #179.

UBS AM first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $599M in Q2 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • UBS AM held 4,274,761 shares of Xylem worth $505M as of Q2 2026.
  • UBS AM bought 440,210 Xylem shares in Q2 2026, an estimated $50.8M.
  • Xylem made up 0.09% of UBS AM's portfolio in Q2 2026, its #179 holding.
  • UBS AM first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Xylem position peaked at $599M in Q2 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.